Proteomics

Dataset Information

0

Hs_BreastCancer

ABSTRACT: Proteomic portrait of human breast cancer progression identifies novel prognostic markers

REANALYSIS of: PXD000309

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Breast

SUBMITTER: Geiger T, Madden SF, Gallagher WM, Cox J, Mann M 

PROVIDER: PAe004809 | PeptideAtlas | 2012-12-31

REPOSITORIES: PeptideAtlas

Json Xml
altmetric image

Publications

Proteomic portrait of human breast cancer progression identifies novel prognostic markers.

Geiger Tamar T   Madden Stephen F SF   Gallagher William M WM   Cox Juergen J   Mann Matthias M  

Cancer research 20120313 9

Breast cancer is the second leading cause of cancer death for women in the United States. Of the different subtypes, estrogen receptor-negative (ER(-)) tumors, which are ErbB2+ or triple-negative, carry a relatively poor prognosis. In this study, we used system-wide analysis of breast cancer proteomes to identify proteins that are associated with the progression of ER(-) tumors. Our two-step approach included an initial deep analysis of cultured cells that were obtained from tumors of defined br  ...[more]

Similar Datasets

Proteomics Targeted inhibition of human breast cancer cell lines selected as model systems of ERBB2-positive/EGFR high breast cancer
2012-10-22 | E-GEOD-36327 | biostudies-arrayexpress
Proteomics E-PROT-26
2021-05-25 | E-PROT-26 | ExpressionAtlas
Proteomics Targeted inhibition of human breast cancer cell lines selected as model systems of ERBB2-positive/EGFR high breast cancer [RPPA-SKBR3]
2012-10-22 | GSE36326 | GEO
Proteomics Targeted inhibition of human breast cancer cell lines selected as model systems of ERBB2-positive/EGFR high breast cancer [RPPA-Longterm]
2012-10-22 | GSE36325 | GEO
Proteomics Targeted inhibition of human breast cancer cell lines selected as model systems of ERBB2-positive/EGFR high breast cancer [RPPA-Longterm-HCC1954-SKBR3]
2014-08-13 | GSE50108 | GEO
Proteomics Targeted inhibition of human breast cancer cell line selected as model system of ERBB2-positive breast cancer [RPPA-Longterm-BT474]
2014-08-13 | GSE50107 | GEO
Proteomics Targeted inhibition of human breast cancer cell line selected as model system of ERBB2-positive/EGFR high breast cancer [RPPA-Shortterm-SKBR3]
2014-08-13 | GSE50106 | GEO
Proteomics Targeted inhibition of human breast cancer cell line selected as model system of ERBB2-positive/EGFR high breast cancer [RPPA-Shortterm-HCC1954]
2014-08-13 | GSE50105 | GEO
Proteomics Targeted inhibition of human breast cancer cell line selected as model system of ERBB2-positive breast cancer [RPPA-Shortterm-BT474]
2014-08-13 | GSE50104 | GEO
Proteomics Targeted inhibition of human breast cancer cell lines selected as model systems of ERBB2-positive/EGFR high breast cancer [RPPA-HCC1954]
2012-10-22 | GSE36324 | GEO